FDA plans to roll out AI agency-wide for reviews in June
Regulatory NewsJoanne S. Eglovitch
Artificial intelligence/machine learning (AI/ML)CBERCDERCDRHLeadershipMedical DevicesPharmaceuticalsProduct developmentRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)